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INTRODUCTION 
Cardiovascular diseases are the most common serious 
diseases in developed countries and they are rapidly 
increasing in developing countries. Although the age 
proportional morality rate for coronary artery disease has 
decreased to two-thirds in the United States during the 
past four decades, but cardiovascular diseases are still the 
most common causes of deaths and account for 
approximately 40 percent of deaths of which almost one 
quarter occurs suddenly. The increasing prevalence of 
obesity, type 2 diabetes and metabolic syndrome, which 
are the major risk factors for atherosclerosis, are now 
considered as a menace to prevent age-adjusted mortality 
rate due to coronary artery disease.
1
 It is estimated that 
cardiovascular diseases, especially atherosclerosis, will 
be the main cause of the disease in the world by 2020.
2
 
Atherosclerosis is a vascular disease that is non-
technically called "atherosclerosis". Today’s models on 
Atherosclerosis are based on the belief that various 
stressors have impaired vascular continuity and have 
caused the accumulation of abnormal fat, cells and 
extracellular matrix in arterial wall. 
These waste products create lesions called 
"atherosclerotic plaque". These plaques may directly 
reduce the diameter of the ductus arteriosus or their 
rupture and cause thrombosis. Both mentioned 
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mechanisms restrict blood flow of the members in distal. 
As a result, the main complications of atherosclerosis 
include angina, myocardial infarction, stroke, and 
reduced blood flow to the kidneys and lower extremities 
that introduce atherosclerosis as the main cause of 
mortality and morbidity in the developed world. 
Despite the high prevalence and after more than one 
hundred years from the recognition of pathological 
features, pathophysiology of atherosclerosis is still an 
interesting topic for widespread and active research. 
Substantial progress has been achieved in recent years. 
Acute coronary syndromes (ACS) are life-threatening 
conditions that can end life in patients with coronary 
artery disease at any time. 
These syndromes range from a pattern of unstable angina 
to the most serious form of acute myocardial infarction 
which is in the form of an irreversible necrosis of heart 
muscle. The prevalence rate of ACS is very high and 
surprising. More than one million and six hundred 
thousand people, suffering from one of these syndromes, 
refer to the hospitals in the United States each year.
3
 
Also Framingham’s study and other studies have shown 
that the risk of ischemic heart disease increases with 
increased cholesterol levels. Coronary risk in patients 
with cholesterol levels of about 240 mg/dl is two times 
more the individuals with 200 mg/dl cholesterol. 
Increased serum levels of LDL are associated with an 
increased incidence of atherosclerosis and coronary heart 
diseases. When the level of LDL is high, it accumulates 
in the sub endothelial space and by causing more changes 
leads to the additional damage to the intima layer and 
results the creation or extension of atherosclerotic lesions. 
When lifestyle changes are not able to provide the desired 
amount of lipids, a group of drugs can be used to treat 
abnormal lipid levels. The most efficient LDL levels 
lowering are inhibitors of HMG-CoA reductase (3-
hydroxy-3-methyl-glutaryl-coenzyme A) which are called 
"statins".
4
 Lovastatin, Atorvastatin, Fluvastatin, 
Pravastatin and Ruvastatin belong to this group. 
Atorvastatin is the most powerful statin drug class that 
can be administered at a dose of 10-80 mg per day. 
Statins are the most effective in LDL reduction. Also 
during treatment with these drugs, a slight reduction in 
plasma triglycerides and a mild increase HDL cholesterol 
levels occur.
5-6
 
Today the measurement of carotid intima-media 
thickness with ultrasound devices with high accuracy is 
possible. The normal thickness is 0.6-0.8 mm, but several 
studies have shown that the thickness, in patients with 
evidence of atheroma, significantly increases in other 
areas such as coronary arteries. Intima-media thickness 
slowly increases with age but it may provide a useful tool 
in the diagnosis of patients with vascular disease.
7
 
Considering the importance of cardiovascular disease and 
complications of acute coronary syndromes such as heart 
attack and the increasing risk of carotid intima-media 
thickness in patients with evidences of atheroma in other 
areas like coronary arteries, this study was conducted in 
order to evaluate the effect of statins carotid intima-media 
thickness in patients with acute coronary syndrome. 
METHODS 
This study was a randomized single-blind clinical trial 
which was conducted on 100 patients with acute coronary 
syndrome such as STEMI or UA and NSTEMI that were 
hospitalized in Ardabil city hospital from April 2014 to 
September 2015. 
After obtaining written informed consent at the time of 
admission of patients, carotid Doppler ultrasound was 
taken from the patients and carotid intima-media 
thickness, the distance between the intima and media to 
adventitia junction, was measured during diastole by 
placing the probe Sono vertically on common carotid 
approximately one centimeter below artery bulb. All 
ultrasounds were taken by one person with two different 
devices in two different hospitals. The size of this 
thickness along with other information of the patients 
including age, sex and history of diseases such as 
hypertension, type 2 diabetes, smoking, hyperlipidemia 
and diagnosis during hospitalization including 
myocardial infarction with ST-segment elevation, 
myocardial infarction without ST-segment elevation, and 
unstable angina were recorded. The patients were divided 
randomly into two groups of 50 patients and were treated 
with atorvastatin 20 and 40 mg which was administered 
routinely to patients. The patients were visited once every 
3 months from the time of taking drug and the liver 
enzymes were checked in patients 3 months after the start 
of medication. The patients were invited for repeated 
measurement of carotid intima-media thickness after 6 
months and additional information was added to the 
form. The collected data were analyzed in SPSS version 
16 software using statistical methods. P <0.05 was 
considered as significant level. 
RESULTS 
In this study 100 patients with the age range of 30-74 
years were studied. The mean age was 52±10 years. The 
mean age in atorvastatin 20 mg group was 52±12 years 
and atorvastatin 40 mg group was 52±9 years. 74% of all 
patients were male and rest of them was female. In 
Atorvastatin 20 mg group, 36 patients (72%) and 
atorvastatin 40 mg group, 42 patients (84%) participated 
with a diagnosis of UA. Of all patients, 21% had no risk 
factor, 23% smoking, 15% diabetes, 25% had high blood 
pressure and 16% had hyperlipidemia. The risk factors 
prevalence difference between the two groups was not 
statistically significant as given in Table 1. 
The analysis of gender, diagnosis and heart disease risk 
factors data were analyzed using chi-square test and in 
general the two groups (atorvastatin 20 mg and 40 mg) 
had a similar demographic characteristics and difference 
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between two groups was not statistically significant. The 
change in the mean of carotid intima-media thickness in 
the atorvastatin 20 mg group was 0.044±0.17 mm and in 
the atorvastatin 40 mg group was -0/006±0/17 mm as 
given in Table 2. 
Table 1: Risk factors in two groups. 
Risk factors 
spuorG 
p-value Atorvastatin 
40 mg n (%) 
Atorvastatin 
20 mg n(%) 
Smoking  10(20) 13(26) 
0.82 
DM type 2 7(14) 8(16) 
HTN 15(30) 10(20) 
Hyperlipi-
demia 
8(16) 8(16) 
Table 2: Compare the average of carotid intima-
media thickness (IMT) in two groups. 
Average of 
IMT at 
different 
time 
intervals 
spuorG 
p-
value 
Atorvastatin 
40 mg n (%) 
Atorvastatin 
20 mg n(%) 
 
Average of 
IMT in 
baseline 
(mm) 
0.88±0.137 0.824±0.163 0.08 
Average of 
IMT after 6 
month 
(mm) 
0.876±0.263 0.868±0.214 0.94 
Change in 
the average 
of IMT 
(mm) 
-0.006±0.168 0.044±0.169 0.14 
DISCUSSION 
In this study it was shown that the mean of carotid artery 
intima-media thickness after 6 months in patients who 
were taking atorvastatin 20 mg has been increased and 
reached to 0.87±0.21 mm and in the atorvastatin 40 mg 
group has slightly been decreased to 0.88 ± 0.26 mm and 
there was no statistically significant difference between 
the two groups. Also changes in the average carotid 
artery intima-media thickness in atorvastatin 20 mg group 
was 0.044±0.17 and in atorvastatin 40 mg group was -
0.006±0.17 mm and the statistically significant difference 
between the two groups was no significant. 
In a randomized clinical trial conducted in 2002 to 
compare the effect of atorvastatin 80 mg per day and 
pravastatin 40 mg per day on carotid intima-media, 161 
patients, with a mean age of 60±11 years and 71.4% were 
male. In this study, the mean intima-media thickness of 
the carotid artery and other characteristics in the baseline 
were similar between two groups and the results showed 
that after 12 months atorvastatin reduced carotid intima-
media thickness, while the thickness in the pravastatin 
group remained stable (P =0.03). It is noteworthy that the 
6-month follow-up study of carotid intima-media 
thickness average in both groups was not significantly 
different (P =0.74) and, in this regard, was similar to our 
study.
8
 
It should be noted that due to lack of routine use of 
atorvastatin 80 mg per day in our country and the 
common use of dose 20 and 40 mg per day, the two doses 
were chosen for comparison and long-term follow-up of 
12 months for patients was not possible because of 
working conditions.  
A study in 2009 compared the effects of ezetimibe + 
statin combination therapy versus statins + fibrates on 
carotid intima-media thickness and showed that: 
After 14 months statins + fibrates combination reduced 
carotid intima-media average and maximum thickness 
whereas statin + ezetimibe increased carotid intima-
media thickness. Also the risk of cardiovascular events in 
the study of niacin was less than ezetimibe that was not 
similar to our study results.
9
 
In 2011 a study conducted on the relationship between 
carotid artery wall intima-media thickness and 
cardiovascular events introduced the measurement value 
of the thickness as a deterioration and progression 
measurement scale of atherosclerosis and in relation with 
cardiovascular events. It was mentioned that during the 
treatment associated with the reduction in intima-media 
thickness of the carotid artery wall, atherosclerosis 
regression occurred and the risk of cardiovascular events 
decreased.
10
 
Demircan et al in his study showed that the intima-media 
thickness in patients who had acute coronary syndrome 
than in those who had stable angina pectoris which was in 
line with our study results.
11
 
In a study done by Shibata in 2014 results showed that 
Pitavastatin may be effective to prevent secondary stroke 
in patients with stroke and hyperlipidemia and the change 
of IMT%/year was less than zero for the Pitavastatin 
group, and was almost zero or higher for the control 
group.
12
 
Nambi and et al in a study showed that Adding plaque 
and carotid intima-media thickness (CIMT) to traditional 
risk factors (TRF) improves coronary heart disease risk 
prediction in the ARIC (atherosclerosis risk in 
communities) study.
13
 
CONCLUSION 
As a result, this comparative trial study shows that the 
short-term daily use of atorvastatin 20 and 40 mg has 
similar effects on carotid artery intima-media thickness. 
However, it is possible that the use of high-dose 
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atorvastatin, 80 mg per day, may show better 
improvement in atherosclerosis as measured by carotid 
artery intima-media thickness. It is also possible that the 
measurement of the intima-media thickness of the 
common carotid artery and internal carotid artery may be 
added to Framingham risk factors to predict 
cardiovascular events in the future.  
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